TABLE 1.
Prevalence of mutations in the connection domain of RT in treated and untreated individuals
| RT codon | Prevalence (untreated)a | Prevalence (treated)b | Increase in prevalence |
|---|---|---|---|
| % | % | % | |
| 277 | 52.93 | 59.83 | 6.90 |
| 286 | 27.27 | 32.72 | 5.45 |
| 288 | 9.53 | 14.10 | 4.57 |
| 348 | 0.80 | 12.10 | 11.30 |
| 356 | 19.12 | 27.18 | 8.07 |
| 358 | 5.42 | 10.85 | 5.43 |
| 359 | 8.90 | 16.36 | 7.46 |
| 360 | 21.36 | 28.82 | 7.47 |
| 371 | 5.35 | 12.66 | 7.31 |
| 386 | 13.26 | 18.00 | 4.74 |
a
The prevalence (in percentage) of amino acid substitutions in the HIV-1 RT from treatment-naive individuals (n = 1606).
b
Prevalence (percentage) of amino acid substitutions in the HIV-1 RT from treatment-experienced individuals (n = 2422).